Decitabine-cedazuridine as first line in acute myeloid leukaemia ineligible for conventional induction chemotherapy

被引：0

作者：

Tauveron-Jalenques, Urbain ^{[1
]}

Lambert, Juliette ^{[2
]}

机构：

[1] CHU Clermont Ferrand, Serv Therapie Cellulaire & Dhematol Clin Adulte, F-63100 Clermont Ferrand, France

[2] Ctr hospitalier Versailles, Serv Dhematol, F-78150 Le Chesna Rocquencourt, France

来源：

BULLETIN DU CANCER | 2024年 / 111卷 / 05期

关键词：

Acute myeloid leukaemia; AML; Decitabine; Cedazuridine; Hypomethylating agent; Unfit;

D O I：

10.1016/j.bulcan.2024.01.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：435 / 436

页数：2

共 50 条

[41] Approaches to induction therapy with adult acute myeloid leukaemia [J].

Bishop, JF .

ACTA HAEMATOLOGICA, 1998, 99 (03) :133-137

[42] Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia [J].

Niscola, Pasquale ;

Neri, Benedetta ;

Catalano, Gianfranco ;

Morino, Luciana ;

Giovannini, Marco ;

Scaramucci, Laura ;

Fratoni, Stefano ;

Noguera, Nelida Ines ;

Cordone, Iole ;

de Fabritiis, Paolo .

ACTA ONCOLOGICA, 2017, 56 (08) :1120-1121

[43] Decitabine as a conditioning regimen in haploidentical stem cell transplantation for refractory acute myeloid leukaemia [J].

Zhang, C. ;

Chen, X. -H. ;

Liu, J. ;

Gao, L. ;

Liu, Y. ;

Gao, L. ;

Kong, P. -Y. ;

Zhang, X. .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) :336-338

[44] Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience [J].

Chen, Yi ;

Cao, Jing ;

Ye, Yaozhen ;

Luo, Luting ;

Zheng, Xiaoyun ;

Yang, Xiaozhu ;

Zheng, Zhihong ;

Zheng, Jing ;

Yang, Ting ;

Hu, Jianda .

JOURNAL OF CHEMOTHERAPY, 2023, 35 (04) :322-329

[45] Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine [J].

Venugopal, Sangeetha ;

Maiti, Abhishek ;

DiNardo, Courtney D. ;

Qiao, Wei ;

Ning, Jing ;

Loghavi, Sanam ;

Daver, Naval G. ;

Kadia, Tapan M. ;

Rausch, Caitlin R. ;

Alvarado, Yesid ;

Ohanian, Maro ;

Sasaki, Koji ;

Short, Nicholas J. ;

Takahashi, Koichi ;

Yilmaz, Musa ;

Ravandi, Farhad ;

Kantarjian, Hagop M. ;

Konopleva, Marina Y. .

LEUKEMIA & LYMPHOMA, 2021, 62 (14) :3501-3505

[46] Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia [J].

Hyunkyung Park ;

Jeonghwan Youk ;

Inho Kim ;

Sung-Soo Yoon ;

Seonyang Park ;

Jeong-Ok Lee ;

Soo-Mee Bang ;

Youngil Koh .

Annals of Hematology, 2016, 95 :1777-1786

[47] Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy [J].

Lazzarotto, Davide ;

Candoni, Anna ;

Nadali, Gianpaolo ;

Pavan, Laura ;

Lessi, Federica ;

Mosna, Federico ;

Simeone, Erica ;

Ventura, Giovanna ;

Gherlinzoni, Filippo ;

Semenzato, Gianpietro ;

Pizzolo, Giovanni ;

Fanin, Renato .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (06) :586-592

[48] Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults [J].

Phillips, Christine L. ;

Davies, Stella M. ;

McMasters, Richard ;

Absalon, Michael ;

O'Brien, Maureen ;

Mo, Jun ;

Broun, Randall ;

Moscow, Jeffrey A. ;

Smolarek, Teresa ;

Garzon, Ramiro ;

Blum, William ;

Schwind, Sebastian ;

Marcucci, Guido ;

Perentesis, John P. .

BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (03) :406-410

[49] Hypoxia impairs decitabine-induced expression of HLA-DR in acute myeloid leukaemia cell lines [J].

Humphries, Sam ;

Burnard, Sean M. ;

Eggins, Courtney D. ;

Keely, Simon ;

Bond, Danielle R. ;

Lee, Heather J. .

CLINICAL EPIGENETICS, 2025, 17 (01)

[50] Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia [J].

Hamadani, Mehdi ;

Awan, Farrukh T. .

HEMATOLOGICAL ONCOLOGY, 2010, 28 (01) :3-12

← 1 2 3 4 5 →